(de-news.net) – BioNTech, the biopharmaceutical company headquartered in Mainz, has formally announced its intention to acquire CureVac, a biotechnology firm based in Tübingen, with the…

(GermanPolicy.com) – BioNTech and Pfizer have started a first clinical trial for a vaccine against the omicron variant of the coronavirus. 1,420 subjects aged 18…